dexmedetomidine has been researched along with Memory Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eldemerdash, OM; Elshaffei, IM; Senousy, MA; Taha, M; Yousef, EM | 1 |
| An, J; Guo, J; Ma, B; Niu, K; Sun, L; Tu, J | 1 |
| Li, S; Liu, J; Wen, Q; Xie, K; Yu, J; Yu, L; Zhu, Y | 1 |
| An, JX; Guo, J; Lu, GF; Niu, K; Qin, JL; Williams, JP | 1 |
| Berardi, A; Campolongo, P; Morena, M; Palmery, M; Peloso, A; Schelling, G; Trezza, V; Valeri, D | 1 |
| Goyagi, T | 1 |
| Choi, IY; Chung, JY; Hwang, L; Jin, JJ; Kim, CJ; Kim, SE; Kim, SH; Ko, IG; Shin, MS; Yi, JW | 1 |
| Benefield, L; Gao, X; Gu, SL; Li, M; Ma, TF; Qin, SJ; Shen, QF; Villarreal, M; Wang, Y; Zhou, L; Zhuang, FZ | 1 |
| Aoyama, B; Kawano, T; Locatelli, FM; Nishigaki, A; Shigematsu-Locatelli, M; Tateiwa, H; Yamanaka, D; Yokoyama, M | 1 |
| Veselis, RA | 1 |
| Alkire, MT; Cahill, LF; Drumheller, KM; Hayama, HR; Mastromonaco, M; Reist, C | 1 |
| Feshchenko, VA; Johnson, R; Reinsel, RA; Veselis, RA | 1 |
2 trial(s) available for dexmedetomidine and Memory Disorders
| Article | Year |
|---|---|
Event-related functional magnetic resonance imaging of a low dose of dexmedetomidine that impairs long-term memory.
Topics: Dexmedetomidine; Emotions; Evoked Potentials; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Long-Term; Photic Stimulation; Psychomotor Performance; Young Adult | 2012 |
Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine.
Topics: Dexmedetomidine; Electroencephalography; Female; Humans; Male; Memory Disorders; Pain Measurement; Propofol; Reaction Time; Thiopental | 2004 |
10 other study(ies) available for dexmedetomidine and Memory Disorders
| Article | Year |
|---|---|
Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation.
Topics: Animals; Brain-Derived Neurotrophic Factor; Dexmedetomidine; Hippocampus; Leucovorin; Male; MAP Kinase Signaling System; Memory Disorders; Methotrexate; MicroRNAs; Neurogenesis; Rats; Rats, Sprague-Dawley | 2023 |
Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C.
Topics: Animals; Cytochromes c; Dexmedetomidine; Hippocampus; Humans; Male; Memory Disorders; Propofol; Rats; Rats, Sprague-Dawley; Spatial Memory | 2023 |
Role of JNK Signaling Pathway in Dexmedetomidine Post-Conditioning-Induced Reduction of the Inflammatory Response and Autophagy Effect of Focal Cerebral Ischemia Reperfusion Injury in Rats.
Topics: Animals; Autophagy; Brain Injuries; Dexmedetomidine; Infarction, Middle Cerebral Artery; Inflammation; JNK Mitogen-Activated Protein Kinases; Learning Disabilities; MAP Kinase Signaling System; Memory Disorders; Rats; Reperfusion Injury | 2019 |
Dexmedetomidine Reverses Postoperative Spatial Memory Deficit by Targeting Surf1 and Cytochrome c.
Topics: Animals; Cytochromes c; Dexmedetomidine; Hippocampus; Male; Memory Disorders; Propofol; Rats; Rats, Sprague-Dawley | 2021 |
Effects of ketamine, dexmedetomidine and propofol anesthesia on emotional memory consolidation in rats: Consequences for the development of post-traumatic stress disorder.
Topics: Animals; Avoidance Learning; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Hypnotics and Sedatives; Inhibition, Psychological; Interpersonal Relations; Ketamine; Male; Memory Disorders; Propofol; Rats; Rats, Sprague-Dawley; Sleep Wake Disorders; Stress Disorders, Post-Traumatic | 2017 |
Dexmedetomidine reduced sevoflurane-induced neurodegeneration and long-term memory deficits in neonatal rats.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Cognition; Conditioning, Classical; Dexmedetomidine; Fear; Female; Male; Maze Learning; Memory; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Sevoflurane | 2019 |
Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus.
Topics: Animals; Apoptosis; Avoidance Learning; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Caspase 3; Cerebral Hemorrhage; Dexmedetomidine; DNA Fragmentation; In Situ Nick-End Labeling; Maze Learning; Memory Disorders; Memory, Short-Term; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptor, trkB | 2013 |
Dexmedetomidine protects against learning and memory impairments caused by electroconvulsive shock in depressed rats: Involvement of the NMDA receptor subunit 2B (NR2B)-ERK signaling pathway.
Topics: Animals; Depressive Disorder, Major; Dexmedetomidine; Electroshock; Hippocampus; Hypnotics and Sedatives; Learning; Male; MAP Kinase Signaling System; Memory Disorders; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2016 |
Preventive effects of dexmedetomidine on the development of cognitive dysfunction following systemic inflammation in aged rats.
Topics: Aging; Animals; Cognitive Dysfunction; Dexmedetomidine; Hippocampus; Hypnotics and Sedatives; Imidazoles; Inflammation; Isoindoles; Isoquinolines; Lipopolysaccharides; Male; Memory Disorders; Neuroprotective Agents; Piperazines; Rats; Signal Transduction | 2017 |
The problem with amnesia.
Topics: Dexmedetomidine; Female; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Long-Term | 2012 |